Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Plos One
|
September 10, 2011
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities
Ran He, Bryan T Mott, Andrew S Rosenthal, et al.
Retrovirology
|
September 30, 2016
Drug resistant integrase mutants cause aberrant HIV integrations
Janani Varadarajan, Mary Jane McWilliams, Bryan T Mott, et al.
Bioorganic & Medicinal Chemistry
|
May 16, 2013
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study
Bryan T Mott, Ran He, Xiaochun Chen, et al.
Journal of Biomolecular Screening
|
November 30, 2012
High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase
Eric S McCoy, Wendy A Lea, Bryan T Mott, et al.
Frontiers in Oncology
|
February 7, 2022
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology
Amanda B Kagan, Blake S Moses, Bryan T Mott, et al.
Journal of Medicinal Chemistry
|
April 9, 2010
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii
Christopher P Hencken, Lorraine Jones-Brando, Claudia Bordón, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 11, 2014
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether
Ryan C Conyers, Jennifer R Mazzone, Maxime A Siegler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2016
Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory site
Monica Kasbekar, Gerhard Fischer, Bryan T Mott, et al.
Cancer Chemotherapy and Pharmacology
|
May 30, 2023
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative
Amanda B Kagan, Blake S Moses, Rena Lapidus, et al.
Journal of Medicinal Chemistry
|
October 16, 2004
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors
Apurba K Bhattacharjee, Jeanne A Geyer, Cassandra L Woodard, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Plos One
|
September 10, 2011
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities
Ran He, Bryan T Mott, Andrew S Rosenthal, et al.
Retrovirology
|
September 30, 2016
Drug resistant integrase mutants cause aberrant HIV integrations
Janani Varadarajan, Mary Jane McWilliams, Bryan T Mott, et al.
Bioorganic & Medicinal Chemistry
|
May 16, 2013
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study
Bryan T Mott, Ran He, Xiaochun Chen, et al.
Journal of Biomolecular Screening
|
November 30, 2012
High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase
Eric S McCoy, Wendy A Lea, Bryan T Mott, et al.
Frontiers in Oncology
|
February 7, 2022
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology
Amanda B Kagan, Blake S Moses, Bryan T Mott, et al.
Journal of Medicinal Chemistry
|
April 9, 2010
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii
Christopher P Hencken, Lorraine Jones-Brando, Claudia Bordón, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 11, 2014
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether
Ryan C Conyers, Jennifer R Mazzone, Maxime A Siegler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2016
Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory site
Monica Kasbekar, Gerhard Fischer, Bryan T Mott, et al.
Cancer Chemotherapy and Pharmacology
|
May 30, 2023
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative
Amanda B Kagan, Blake S Moses, Rena Lapidus, et al.
Journal of Medicinal Chemistry
|
October 16, 2004
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors
Apurba K Bhattacharjee, Jeanne A Geyer, Cassandra L Woodard, et al.
Page
of 6